Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Puma Biotechnology stock has a target of 7.00, which predicts an increase of 139.32% from the current stock price of 2.93.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$7.00	$7.00	$7.00
Change	+139.32%	+139.32%	+139.32%	+139.32%

* Price targets were last updated on Feb 28, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Puma Biotechnology is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+139.32%	Feb 28, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+139.32%	Dec 23, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+139.32%	Nov 20, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+139.32%	Nov 8, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+139.32%	Aug 2, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

209.92M

Decreased by -8.92%

from 230.47M

Revenue Next Year

216.78M

Increased by 3.27%

from 209.92M

EPS This Year

0.35

Decreased by -44.12%

from 0.62

EPS Next Year

0.32

Decreased by -8.73%

from 0.35

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	225.11M	253.16M	228.03M	235.64M	230.47M	209.92M	216.78M	220.18M
Revenue Growth	-17.32%	12.46%	-9.92%	3.34%	-2.19%	-8.92%	3.27%	1.57%
EPS	-1.52	-0.72	0.00	0.45	0.62	0.35	0.32	-0.01
EPS Growth	-	-	-	1,022,625.00%	37.78%	-44.12%	-8.73%	-
Forward PE	-	-	-	-	-	8.44	9.25	-
No. Analysts	-	-	-	-	-	5	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	231.0M	247.4M	261.0M
Avg	209.9M	216.8M	220.2M
Low	177.4M	180.3M	179.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	0.2%	17.8%	20.4%
Avg	-8.9%	3.3%	1.6%
Low	-23.0%	-14.1%	-17.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	0.59	0.89	-0.01
Avg	0.35	0.32	-0.01
Low	0.20	-0.05	-0.01

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-5.2%	157.6%	-
Avg	-44.1%	-8.7%	-
Low	-67.0%	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.